Mendel Money Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$962K Buy
6,415
+3,180
+98% +$346K 0.35% 77
2026
Q1
$299K Sell
3,235
-675
-17% -$67.8K 0.13% 125
2025
Q4
$399K Sell
3,910
-545
-12% -$48.8K 0.17% 113
2025
Q3
$278K Sell
4,455
-400
-8% -$21.8K 0.12% 135
2025
Q2
$253K Buy
+4,855
New +$217K 0.11% 132

Other funds holding GH

Mendel Money Management's GH Position: Q2 2026 in Review

Mendel Money Management increased its Guardant Health (GH) stake by 98% in Q2 2026, buying an estimated $346K and bringing the position to 6,415 shares worth $962K. The position accounts for 0.35% of the portfolio, ranked #77.

Mendel Money Management first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Mendel Money Management held 6,415 shares of Guardant Health worth $962K as of Q2 2026.
  • Mendel Money Management bought 3,180 Guardant Health shares in Q2 2026, an estimated $346K.
  • Guardant Health made up 0.35% of Mendel Money Management's portfolio in Q2 2026, its #77 holding.
  • Mendel Money Management first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Mendel Money Management's 13F filing for Q2 2026, filed 30 Jul 2026.